会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • NOVEL ANTIBODY THERAPIES
    • NEUARTIGEANTIKÖRPERTHERAPIEN
    • EP2205277A1
    • 2010-07-14
    • EP08841962.7
    • 2008-10-22
    • Genmab A/S
    • GOLAB, JakubWINIARSKA, MagdalenaPARREN, PaulMACKUS, WendyENGELBERTS, Patrick
    • A61K39/395C07K16/28
    • C07K16/2887A61K39/39558A61K45/06C07K2317/732C07K2317/734A61K2300/00
    • Antibody capable of mediating effector function which specifically binds to a multiple membrane spanning antigen or to an antigen which forms dimers or multimers (i) for use in combination with a cholesterol-increasing agent in the treatment of a disease or disorder associated with said antigen, wherein antibody-induced effector function has a beneficial effect on said disease ordisorder or (ii) for use in the treatment of such disease or disorder, wherein the antibody is to be administered to a subject undergoing therapy with a cholesterol-lowering agent, such as a statin, and wherein the subject is withdrawn from treatment with the cholesterol-lowering agent prior to the administration of the antibody. Furthermore, a kit of parts comprising such antibody as well as a cholesterol-increasing agent.
    • 能够介导效应子功能的抗体,其特异性结合跨越抗原的多重膜或形成二聚体或多聚体的抗原(i)与胆固醇增加剂组合用于治疗与所述抗原相关的疾病或病症, 其中抗体诱导的效应子功能对所述疾病或病症具有有益作用,或(ii)用于治疗这种疾病或病症,其中抗体将被施用于经历降胆固醇药物治疗的受试者,例如 作为他汀类,并且其中所述受试者在施用所述抗体之前用所述胆固醇降低剂从所述治疗中撤出。 此外,还包括一种包含这种抗体以及胆固醇增加剂的试剂盒。